메뉴 건너뛰기




Volumn 33, Issue 2, 2010, Pages 119-128

Characteristics, cardiovascular comorbidity and medicines management in patients with type 2 diabetes and CKD: Results of the IRIDIEM study

Author keywords

Anaemia; Chronic kidney disease; Clinical practice; Diabetes mellitus; Epoetin; Guideline targets; Risk factors

Indexed keywords

ANTIHYPERTENSIVE AGENT; IRON; RECOMBINANT ERYTHROPOIETIN;

EID: 77951225203     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000313595     Document Type: Article
Times cited : (16)

References (51)
  • 1
    • 2342466734 scopus 로고    scopus 로고
    • Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030
    • Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-1053.
    • (2004) Diabetes Care , vol.27 , pp. 1047-1053
    • Wild, S.1    Roglic, G.2    Green, A.3    Sicree, R.4    King, H.5
  • 3
    • 0003926985 scopus 로고    scopus 로고
    • US Renal Data System: USRDS, Bethesda, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, US Department of Health and Human Services, 2007
    • US Renal Data System: USRDS 2007 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, US Department of Health and Human Services, 2007.
    • (2007) Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States
  • 4
    • 33947407755 scopus 로고    scopus 로고
    • Assessing the prevalence, monitoring and management of chronic kidney disease in patients with diabetes compared with those without diabetes in general practice
    • New JP, Middleton RJ, Klebe B, Farmer CK, de Lusignan S, Stevens PE, O'Donoghue D: Assessing the prevalence, monitoring and management of chronic kidney disease in patients with diabetes compared with those without diabetes in general practice. Diabet Med 2007; 24: 364-369.
    • (2007) Diabet Med , vol.24 , pp. 364-369
    • New, J.P.1    Middleton, R.J.2    Klebe, B.3    Farmer, C.K.4    De Lusignan, S.5    Stevens, P.E.6    O'Donoghue, D.7
  • 5
    • 0032737294 scopus 로고    scopus 로고
    • Endstage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions
    • Ritz E, Rychlik I, Locatelli F, Halimi S: Endstage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions. Am J Kidney Dis 1999; 34: 795-808.
    • (1999) Am J Kidney Dis , vol.34 , pp. 795-808
    • Ritz, E.1    Rychlik, I.2    Locatelli, F.3    Halimi, S.4
  • 7
    • 33846231400 scopus 로고    scopus 로고
    • All-cause and cardiovascular mortality in diabetic subjects increases significantly with reduced estimated glomerular filtration rate: 10 years' data from the South Tees Diabetes Mortality Study
    • Nag S, Bilous R, Kelly W, Jones S, Roper N, Connolly V: All-cause and cardiovascular mortality in diabetic subjects increases significantly with reduced estimated glomerular filtration rate: 10 years' data from the South Tees Diabetes Mortality Study. Diabet Med 2007; 24: 10-17.
    • (2007) Diabet Med , vol.24 , pp. 10-17
    • Nag, S.1    Bilous, R.2    Kelly, W.3    Jones, S.4    Roper, N.5    Connolly, V.6
  • 11
    • 0042991266 scopus 로고    scopus 로고
    • Anaemia in patients with diabetes: Unrecognised, undetected and untreated?
    • Stevens PE, O'Donoghue D, Lameire NR: Anaemia in patients with diabetes: unrecognised, undetected and untreated? Curr Med Res Opin 2003; 19: 395-401.
    • (2003) Curr Med Res Opin , vol.19 , pp. 395-401
    • Stevens, P.E.1    O'Donoghue, D.2    Lameire, N.R.3
  • 12
    • 0032543872 scopus 로고    scopus 로고
    • Pathogenesis, prevention, and treatment of diabetic nephropathy
    • Cooper ME: Pathogenesis, prevention, and treatment of diabetic nephropathy. Lancet 1998; 352: 213-219.
    • (1998) Lancet , vol.352 , pp. 213-219
    • Cooper, M.E.1
  • 13
    • 0032511583 scopus 로고    scopus 로고
    • Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
    • UK Prospective Diabetes Study (UKPDS) Group
    • UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
    • (1998) Lancet , vol.352 , pp. 837-853
  • 14
    • 0027370108 scopus 로고
    • The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
    • The Diabetes Control and Complications Trial Research Group
    • The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
    • (1993) N Engl J Med , vol.329 , pp. 977-986
  • 15
    • 33746526038 scopus 로고    scopus 로고
    • Anemia, chronic renal disease and congestive heart failure - The cardiorenal anemia syndrome: The need for cooperation between cardiologists and nephrologists
    • Silverberg DS, Wexler D, Iaina A, Steinbruch S, Wollman Y, Schwartz D: Anemia, chronic renal disease and congestive heart failure -the cardiorenal anemia syndrome: the need for cooperation between cardiologists and nephrologists. Int Urol Nephrol 2006; 38: 295-310.
    • (2006) Int Urol Nephrol , vol.38 , pp. 295-310
    • Silverberg, D.S.1    Wexler, D.2    Iaina, A.3    Steinbruch, S.4    Wollman, Y.5    Schwartz, D.6
  • 17
    • 33646345152 scopus 로고    scopus 로고
    • KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease
    • National Kidney Foundation
    • National Kidney Foundation: KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease. Am J Kidney Dis 2006; 47: 11-145.
    • (2006) Am J Kidney Dis , vol.47 , pp. 11-145
  • 18
    • 77953291613 scopus 로고    scopus 로고
    • Guidelines on diabetes, pre-diabetes and cardiovascular diseases: Executive summary
    • Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
    • Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD): Guidelines on diabetes, pre-diabetes and cardiovascular diseases: executive summary. Eur Heart J 2007; 28: 136.
    • (2007) Eur Heart J , vol.28 , pp. 136
  • 20
    • 58649094413 scopus 로고    scopus 로고
    • Anaemia management in patients with chronic kidney disease: A position statement by the Anaemia Working Group of European Renal Best Practice
    • Locatelli F, Covic A, Eckardt KU, Wiecek A, Vanholder R: Anaemia management in patients with chronic kidney disease: a position statement by the Anaemia Working Group of European Renal Best Practice. Nephrol Dial Transplant 2009; 24: 348-354.
    • (2009) Nephrol Dial Transplant , vol.24 , pp. 348-354
    • Locatelli, F.1    Covic, A.2    Eckardt, K.U.3    Wiecek, A.4    Vanholder, R.5
  • 21
    • 3042819708 scopus 로고    scopus 로고
    • K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease
    • KDOQI
    • KDOQI: K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease. Am J Kidney Dis 2004; 43:S1-S290.
    • (2004) Am J Kidney Dis , vol.43
  • 23
    • 33846642617 scopus 로고    scopus 로고
    • Target level for hemoglobin correction in patients with diabetes and CKD: Primary results of the Anemia Correction in Diabetes (ACORD) Study
    • Ritz E, Laville M, Bilous RW, O'Donoghue D, Scherhag A, Burger U, de Alvaro F: Target level for hemoglobin correction in patients with diabetes and CKD: primary results of the Anemia Correction in Diabetes (ACORD) Study. Am J Kidney Dis 2007; 49: 194-207.
    • (2007) Am J Kidney Dis , vol.49 , pp. 194-207
    • Ritz, E.1    Laville, M.2    Bilous, R.W.3    O'Donoghue, D.4    Scherhag, A.5    Burger, U.6    De Alvaro, F.7
  • 26
    • 33645968441 scopus 로고    scopus 로고
    • Functional erythropoietin deficiency in patients with type 2 diabetes and anaemia
    • Thomas MC, Tsalamandris C, Macisaac R, Jerums G: Functional erythropoietin deficiency in patients with type 2 diabetes and anaemia. Diabet Med 2006; 23: 502-509.
    • (2006) Diabet Med , vol.23 , pp. 502-509
    • Thomas, M.C.1    Tsalamandris, C.2    MacIsaac, R.3    Jerums, G.4
  • 27
    • 0034011821 scopus 로고    scopus 로고
    • Predictors of hospitalization and death among pre-dialysis patients: A retrospective cohort study
    • Holland DC, Lam M: Predictors of hospitalization and death among pre-dialysis patients: a retrospective cohort study. Nephrol Dial Transplant 2000; 15: 650-658.
    • (2000) Nephrol Dial Transplant , vol.15 , pp. 650-658
    • Holland, D.C.1    Lam, M.2
  • 28
    • 0020069360 scopus 로고
    • Predicting survival in adults with end-stage renal disease: An age equivalence index
    • Hutchinson TA, Thomas DC, MacGibbon B: Predicting survival in adults with end-stage renal disease: an age equivalence index. Ann Intern Med 1982; 96: 417-423.
    • (1982) Ann Intern Med , vol.96 , pp. 417-423
    • Hutchinson, T.A.1    Thomas, D.C.2    MacGibbon, B.3
  • 29
    • 0030794039 scopus 로고    scopus 로고
    • Risk factors for development of diabetic nephropathy: A review
    • Strojek K, Grzeszczak W, Ritz E: Risk factors for development of diabetic nephropathy: a review. Nephrol Dial Transplant 1997; 12(suppl 2):24-26. (Pubitemid 27331300)
    • (1997) Nephrology Dialysis Transplantation , vol.12 , Issue.SUPPL. 2 , pp. 24-26
    • Strojek, K.1    Grzeszczak, W.2    Ritz, E.3
  • 30
    • 0028364363 scopus 로고
    • Biochemical risk factors in type 2 diabetic patients at diagnosis compared with agematched normal subjects
    • UK Prospective Diabetes Study (UKPDS) XI
    • UK Prospective Diabetes Study (UKPDS): XI: Biochemical risk factors in type 2 diabetic patients at diagnosis compared with agematched normal subjects: Diabet Med 1994; 11: 534-544.
    • (1994) Diabet Med , vol.11 , pp. 534-544
  • 31
    • 4344640566 scopus 로고    scopus 로고
    • Individualized risk management in diabetics: How to implement best practice guidelines -design and concept of the IRIDIEM studies
    • Lameire N, Stevens P, Raptis S, Thomas S, Schernthaner G: Individualized risk management in diabetics: how to implement best practice guidelines -design and concept of the IRIDIEM studies. Kidney Blood Press Res 2004; 27: 127-133.
    • (2004) Kidney Blood Press Res , vol.27 , pp. 127-133
    • Lameire, N.1    Stevens, P.2    Raptis, S.3    Thomas, S.4    Schernthaner, G.5
  • 33
    • 34547615709 scopus 로고    scopus 로고
    • The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
    • The task force for the management of arterial hypertension of the European Society of Hypertension The task force for the management of arterial hypertension of the European Society of Cardiology 2007 guidelines for the management of arterial hypertension
    • Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, et al; The task force for the management of arterial hypertension of the European Society of Hypertension, The task force for the management of arterial hypertension of the European Society of Cardiology: 2007 guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007; 28: 1462-1536.
    • (2007) Eur Heart J , vol.28 , pp. 1462-1536
    • Mancia, G.1    De Backer, G.2    Dominiczak, A.3    Cifkova, R.4    Fagard, R.5    Germano, G.6    Grassi, G.7    Heagerty, A.M.8    Kjeldsen, S.E.9    Laurent, S.10    Narkiewicz, K.11    Ruilope, L.12
  • 34
    • 0344718782 scopus 로고    scopus 로고
    • 2003 World Health Organization/ International Society of Hypertension statement on management of hypertension
    • Whitworth JA: 2003 World Health Organization/ International Society of Hypertension statement on management of hypertension. J Hypertens 2003; 21: 1983-1992.
    • (2003) J Hypertens , vol.21 , pp. 1983-1992
    • Whitworth, J.A.1
  • 35
    • 0035228407 scopus 로고    scopus 로고
    • K/DOQI clinical practice guidelines for anemia of chronic kidney disease
    • National Kidney Foundation
    • National Kidney Foundation: K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease. Am J Kidney Dis 2000; 37:S182-S238.
    • (2000) Am J Kidney Dis , vol.37
  • 36
    • 0018417780 scopus 로고
    • Nutritional anemia: Its understanding and control with special reference to the work of the World Health Organization
    • Baker SJ, DeMaeyer EM: Nutritional anemia: its understanding and control with special reference to the work of the World Health Organization. Am J Clin Nutr 1979; 32: 368-417.
    • (1979) Am J Clin Nutr , vol.32 , pp. 368-417
    • Baker, S.J.1    De Maeyer, E.M.2
  • 39
    • 52649122798 scopus 로고    scopus 로고
    • ORAMA: A study to investigate EBPG impact on renal anaemia -design and baseline data
    • Locatelli F, Covic A, Macdougall IC, Wiecek A: ORAMA: a study to investigate EBPG impact on renal anaemia -design and baseline data. J Nephrol 2008; 21: 592-603.
    • (2008) J Nephrol , vol.21 , pp. 592-603
    • Locatelli, F.1    Covic, A.2    MacDougall, I.C.3    Wiecek, A.4
  • 40
    • 33745904432 scopus 로고    scopus 로고
    • Clinical characteristics of chronic kidney disease patients with and without diabetes: A subanalysis of the PAERI study
    • Lorber D, Reddan D: Clinical characteristics of chronic kidney disease patients with and without diabetes: a subanalysis of the PAERI study. Clin Nephrol 2006; 66: 11-16.
    • (2006) Clin Nephrol , vol.66 , pp. 11-16
    • Lorber, D.1    Reddan, D.2
  • 41
    • 18744368790 scopus 로고    scopus 로고
    • Renin-angiotensin-aldosterone system blockade and renal protection: Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers?
    • Ruilope LM: Renin-angiotensin-aldosterone system blockade and renal protection: angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers? Acta Diabetol 2005; 42(suppl 1):S33-S41.
    • (2005) Acta Diabetol , vol.42 , Issue.SUPPL. 1
    • Ruilope, L.M.1
  • 42
    • 9144270451 scopus 로고    scopus 로고
    • Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European Society of Cardiology
    • Patrono C, Bachmann F, Baigent C, Bode C, De Caterina R, Charbonnier B, Fitzgerald D, Hirsh J, Husted S, Kvasnicka J, Montalescot G, et al: Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European Society of Cardiology. Eur Heart J 2004; 25: 166-181.
    • (2004) Eur Heart J , vol.25 , pp. 166-181
    • Patrono, C.1    Bachmann, F.2    Baigent, C.3    Bode, C.4    De Caterina, R.5    Charbonnier, B.6    Fitzgerald, D.7    Hirsh, J.8    Husted, S.9    Kvasnicka, J.10    Montalescot, G.11
  • 47
    • 19044397278 scopus 로고    scopus 로고
    • Results of the European Survey on Anaemia Management 2003 ESAM 2003): Current status of anaemia management in dialysis patients, factors affecting epoetin dosage and changes in anaemia management over the last 5 years
    • Jacobs C, Frei D, Perkins AC: Results of the European Survey on Anaemia Management 2003 (ESAM 2003): current status of anaemia management in dialysis patients, factors affecting epoetin dosage and changes in anaemia management over the last 5 years. Nephrol Dial Transplant 2005; 20: 3-24.
    • (2005) Nephrol Dial Transplant , vol.20 , pp. 3-24
    • Jacobs, C.1    Frei, D.2    Perkins, A.C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.